After-Hours Stock Movers 12/14: (GRTX) (CFVI) (DWAC) Higher; (LESL) (LEGN) (PK) Lower (more...)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq end lower on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Needham Starts NeoVolta (NEOV) at Buy
Legend Biotech (LEGN) Prices 7.5M Share Offering at $40/sh
December 16, 2021 9:19 AM ESTLegend Biotech Corporation (NASDAQ: LEGN), a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications, today announced that it has priced an underwritten public offering of 7,500,000 American depositary shares (ADSs), each representing two ordinary shares, at a public offering price of $40.00 per ADS, for total gross proceeds of approximately $300.0 million. In addition, Legend Biotech has granted the underwriters a 30-day option to purchase up to an additional 1,125,000 ADSs at the public offering price, less underwriting discounts and commissions. All of the ADSs are being... More
Leslie's, Inc. (LESL) Prices 12.5M Share Offering
December 15, 2021 7:30 AM ESTLeslies, Inc. (the Company or Leslies) (Nasdaq: LESL) today announced the pricing of an underwritten public offering of 12,500,000 shares of common stock (the Offering) by certain of the Companys non-management stockholders (the Selling Stockholders). The Selling Stockholders have also granted the underwriters a 30-day option to purchase up to an additional 1,875,000 shares of common stock. The Selling Stockholders will receive all of the proceeds from the Offering. Leslies is not offering any shares of its common stock in the Offering and will not receive any proceeds from the Offering, including from any exercise by the... More

